Agilent, GKSB-318, AdvanceBio 2-AB G2FGa2 / FA2G2Ga(3)2 N-glycan Standard

AdvanceBio 2-AB G2FGa2 / FA2G2Ga(3)2 N-glycan Standard . N-glycan [asialo-, di-galactosylated galactose biantennary, core-subsituted with fucose and with 2 α(1,3) galactose] labeled with 2-aminobenzamide (2-AB), for use as a qualitative standard in applications such as liquid chromatography (LC). Alternative glycan names: G2F with 2 alpha gal, F(6)A2G2Ga2, NA2Ga2F.

Specifications:
Chemical Structure:
Label: 2-AB
Monoisotopic Mass: MWGlycan + 120.06875 = 2230.8244
Name: G2FGa2
Oxford Name: F(6)A2G(4)2Ga(3)2
Standard Type: Complex-type Native N-Glycan
Unit: 100 pmol

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The AdvanceBio 2-AB G2FGa2 / FA2G2Ga(3)2 N-glycan Standard is designed to support robust and reliable N-glycan analysis in biopharmaceutical research and development. This standard provides two well-characterized, 2-aminobenzamide (2-AB) labeled N-glycan structures, enabling accurate monitoring and quantitation during glycan profiling workflows. Suitable for use as a positive control or for system suitability checks, it streamlines method development, validation, and routine quality assessments.

Ideal for laboratories engaged in monoclonal antibody characterization, biosimilar comparison, or glycoprotein analysis, this standard enhances the confidence and reproducibility of results. When integrated into liquid chromatography and mass spectrometry procedures, it assists in optimizing glycan separation and detection parameters. The standard is fully compatible with Agilent AdvanceBio Glycan Mapping columns and Agilent LC and LC-MS systems, ensuring seamless integration into existing analytical platforms.

Its precise and consistent composition facilitates the establishment of chromatographic retention times and serves as a reference for structural assignment. The product aligns with regulatory expectations for glycan analysis in pharmaceutical quality control, providing essential support for the development and approval process of therapeutic proteins.